Our News

Our News

Find out about the latest events and advancements. This summarizes our press releases and latest events information.

2020

GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases

Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason

Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason

Dr. Harrison Awarded First NOSTER Science Microbiome Prize

COVID-19 Research Continues

Benaroya Research Institute Launches Gut Research Program

Hamid Bolouri, PhD, named Associate Member in the Center for Systems Immunology at Benaroya Research Institute at Virginia Mason

Benaroya Research Institute Receives $5.4 Million NIH Contract Award to Improve Treatment for Patients with Rheumatoid Arthritis

BRI’s Immune Tolerance Network Launches BEAT-MS Clinical Trial for MS

2019

Benaroya Research Institute Opens the Sound Life Project, A Research Study of Healthy Immune Systems

Type 1 Diabetes Discovery Opens Door to Game-Changing Treatment Strategies

Benaroya Research Institute Receives $4.5 Million Grant to Predict Which Cancer Patients will Benefit from Immunotherapy

Skin Immune Cell Discovery Challenges Beliefs About T Cells and How They Protect Against Infection

Two-Step Expansion and VR Technique Enlarges Tiny Microbes, Illuminating New Ways to Prevent and Treat Disease

Immunotherapy delays type 1 diabetes diagnosis in people at high risk

Pages